• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆碱能核4灰质密度与帕金森病中的冷漠情绪相关。

Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's disease.

作者信息

Sperling Scott A, Druzgal Jason, Blair Jamie C, Flanigan Joseph L, Stohlman Shelby L, Barrett Matthew J

机构信息

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.

出版信息

Clin Neuropsychol. 2023 Apr;37(3):676-694. doi: 10.1080/13854046.2022.2065362. Epub 2022 Apr 21.

DOI:10.1080/13854046.2022.2065362
PMID:35443870
Abstract

The generation and maintenance of goal-directed behavior is subserved by multiple brain regions that receive cholinergic inputs from the cholinergic nucleus 4 (Ch4). It is unknown if Ch4 degeneration contributes to apathy in Parkinson's disease (PD). We analyzed data from 106 pre-surgical patients with PD who had brain MRIs and completed the Frontal Systems Behavior Scales (FrSBe). Eighty-eight patients also completed the Beck Depression Inventory-2nd Edition. Cholinergic basal forebrain grey matter densities (GMD) were measured by applying probabilistic maps to T1 MPRAGE sequences processed using voxel-based morphometry methods. We used linear and hierarchical regression modelling to examine the association between Ch4 GMD and the FrSBe Apathy subscale scores. We used similar methods to assess the specificity of this association and potential associations between Ch4 target regions and apathy. Ch4 GMD ( = .021) and Ch123 GMD ( = .032) were significantly associated with Apathy subscale scores on univariate analysis. Ch4 GMD, but not Ch123 GMD, remained significantly associated with apathy when adjusting for age, sex, levodopa equivalent doses, and disease duration. Centromedial amygdala GMD, which receives cholinergic inputs from Ch4, was also associated with apathy. Ch4 GMD was not associated with depression or disinhibition, nor was it associated with executive dysfunction when adjusting for clinical and demographic variables. Ch4 GMD is specifically associated with apathy in PD. Ch4 degeneration results in cholinergic denervation of multiple cortical and limbic regions, which may contribute to the cognitive and emotional-affective processing deficits that underlie the behavioral symptoms of apathy.

摘要

目标导向行为的产生和维持由多个接受来自胆碱能核4(Ch4)胆碱能输入的脑区所支持。尚不清楚Ch4变性是否导致帕金森病(PD)中的冷漠。我们分析了106例接受手术前的PD患者的数据,这些患者进行了脑部MRI检查并完成了额叶系统行为量表(FrSBe)。88例患者还完成了贝克抑郁量表第二版。通过将概率图谱应用于使用基于体素的形态计量学方法处理的T1 MPRAGE序列来测量胆碱能基底前脑灰质密度(GMD)。我们使用线性和分层回归模型来检查Ch4 GMD与FrSBe冷漠分量表得分之间的关联。我们使用类似的方法来评估这种关联的特异性以及Ch4靶区域与冷漠之间的潜在关联。在单变量分析中,Ch4 GMD(=0.021)和Ch123 GMD(=0.032)与冷漠分量表得分显著相关。在调整年龄、性别、左旋多巴等效剂量和病程后,Ch4 GMD而非Ch123 GMD仍与冷漠显著相关。接受来自Ch4胆碱能输入的中央内侧杏仁核GMD也与冷漠相关。在调整临床和人口统计学变量后,Ch4 GMD与抑郁或去抑制无关,也与执行功能障碍无关。Ch4 GMD与PD中的冷漠特异性相关。Ch4变性导致多个皮质和边缘区域的胆碱能去神经支配,这可能导致作为冷漠行为症状基础的认知和情感加工缺陷。

相似文献

1
Cholinergic nucleus 4 grey matter density is associated with apathy in Parkinson's disease.胆碱能核4灰质密度与帕金森病中的冷漠情绪相关。
Clin Neuropsychol. 2023 Apr;37(3):676-694. doi: 10.1080/13854046.2022.2065362. Epub 2022 Apr 21.
2
Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease.帕金森病中胆碱能核团4萎缩与步态障碍
J Neurol. 2021 Jan;268(1):95-101. doi: 10.1007/s00415-020-10111-2. Epub 2020 Jul 28.
3
Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease.嗅觉、胆碱能基底前脑退行性变与早期帕金森病认知功能障碍。
Parkinsonism Relat Disord. 2021 Sep;90:27-32. doi: 10.1016/j.parkreldis.2021.07.024. Epub 2021 Jul 27.
4
Cholinergic nucleus degeneration and its association with gait impairment in Parkinson's disease.胆碱能核团变性与帕金森病步态障碍的关系。
J Neuroeng Rehabil. 2024 Jul 18;21(1):120. doi: 10.1186/s12984-024-01417-7.
5
Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.容积较小,损伤更重:胆碱能基底前脑灰质密度降低与帕金森病认知障碍有关。
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1251-1256. doi: 10.1136/jnnp-2019-320450. Epub 2019 Jun 7.
6
Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder.孤立性快速眼动睡眠行为障碍中的胆碱能核 4 退化和认知障碍。
Mov Disord. 2023 Mar;38(3):474-479. doi: 10.1002/mds.29306. Epub 2023 Jan 4.
7
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.脑内基底前脑胆碱能神经元萎缩与帕金森病患者认知功能下降相关。
Brain. 2018 Jan 1;141(1):165-176. doi: 10.1093/brain/awx310.
8
Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.非痴呆型帕金森病伴淡漠患者的关键执行和奖励相关节点灰质体积减少。
Brain Imaging Behav. 2017 Oct;11(5):1334-1342. doi: 10.1007/s11682-016-9607-5.
9
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.梅尼埃基底核退化先于帕金森病认知障碍,并可预测其发生。
Brain. 2018 May 1;141(5):1501-1516. doi: 10.1093/brain/awy072.
10
Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.帕金森病患者的灰质体积减少与额认知和行为障碍有关。
J Neurol Sci. 2018 Jul 15;390:231-238. doi: 10.1016/j.jns.2018.05.005. Epub 2018 May 7.

引用本文的文献

1
Choline Alphoscerate: A Therapeutic Option for the Management of Subthreshold Depression in the Older Population.α-甘油磷酸胆碱:老年人群亚阈值抑郁管理的一种治疗选择。
Geriatrics (Basel). 2025 Feb 20;10(2):32. doi: 10.3390/geriatrics10020032.
2
Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson's Disease.中枢胆碱能神经系统在帕金森病运动和非运动症状中的作用
Curr Neuropharmacol. 2025;23(10):1232-1248. doi: 10.2174/011570159X368923250313045859.
3
The neural basis of neuropsychiatric symptoms in Alzheimer's disease.
阿尔茨海默病神经精神症状的神经基础。
Front Aging Neurosci. 2024 Dec 5;16:1487875. doi: 10.3389/fnagi.2024.1487875. eCollection 2024.
4
Parkinson's Disease Mild Cognitive Impairment with MRI evidence of Cholinergic Nucleus 4 Degeneration: A New Subtype?伴有胆碱能核4变性MRI证据的帕金森病轻度认知障碍:一种新亚型?
Res Sq. 2024 Nov 11:rs.3.rs-5278177. doi: 10.21203/rs.3.rs-5278177/v1.
5
Behavioral disorders in Parkinson disease: current view.帕金森病中的行为障碍:当前观点
J Neural Transm (Vienna). 2025 Feb;132(2):169-201. doi: 10.1007/s00702-024-02846-3. Epub 2024 Oct 25.
6
Meso-cortical pathway damage in cognition, apathy and gait in cerebral small vessel disease.脑小血管病认知、淡漠和步态障碍的皮质下通路损伤。
Brain. 2024 Nov 4;147(11):3804-3816. doi: 10.1093/brain/awae145.
7
The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review.雷瓦司汀对帕金森病早期神经精神症状的影响:系统评价。
Eur J Neurol. 2024 Feb;31(2):e16142. doi: 10.1111/ene.16142. Epub 2023 Nov 17.
8
Imaging the Limbic System in Parkinson's Disease-A Review of Limbic Pathology and Clinical Symptoms.帕金森病边缘系统成像——边缘病理学与临床症状综述
Brain Sci. 2022 Sep 15;12(9):1248. doi: 10.3390/brainsci12091248.